Patents by Inventor René Denner
René Denner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11951042Abstract: A device and method for the pre-display of a spot pattern to be applied for a laser treatment of the eye. The spot patterns to be applied are displayed to the operator in advance with the aid of a target beam. The device for the pre-display of a spot pattern to be applied for a laser treatment of the eye includes a laser system and a scanning system for generating a target beam. Here, the laser system and the scanning system for generating the target beam are formed to generate one or more lines which overlie all the spots of the spot pattern of a planned laser treatment. The device and method are suitable for laser treatment of the retina, the trabecular meshwork as well as other regions. Here, it is irrelevant whether what the laser treatment to be applied is.Type: GrantFiled: April 4, 2019Date of Patent: April 9, 2024Assignee: Carl Zeiss Meditec AGInventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer
-
Patent number: 11766357Abstract: A device for superimposing parameters and/or image data in the stereoscopic observation path of ophthalmological devices relates to an apparatus for reflecting relevant parameters and/or image data into the stereoscopic observation beam path of ophthalmic devices, for example for therapeutic laser treatments of an eye. The device includes an additional micro-display, which is connected to the control unit, and a beam deflection element for reflecting the parameters and/or image data shown on the micro-display into the stereoscopic observation beam path, which are for example arranged in the parallel beam path. Even though the apparatus is intended for ophthalmic devices for therapeutic laser treatment in the eye, it can also be used, in principle, for ophthalmic devices for examination, diagnosis and surgical interventions.Type: GrantFiled: September 28, 2018Date of Patent: September 26, 2023Assignee: Carl Zeiss Meditec AGInventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer, Rolf Teuscher
-
Patent number: 11660231Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.Type: GrantFiled: March 16, 2021Date of Patent: May 30, 2023Assignee: Carl Zeiss Meditec AGInventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer
-
Publication number: 20210196519Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.Type: ApplicationFiled: March 16, 2021Publication date: July 1, 2021Inventors: Manfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER
-
Publication number: 20210154048Abstract: A device and method for the pre-display of a spot pattern to be applied for a laser treatment of the eye. The spot patterns to be applied are displayed to the operator in advance with the aid of a target beam. The device for the pre-display of a spot pattern to be applied for a laser treatment of the eye includes a laser system and a scanning system for generating a target beam. Here, the laser system and the scanning system for generating the target beam are formed to generate one or more lines which overlie all the spots of the spot pattern of a planned laser treatment. The device and method are suitable for laser treatment of the retina, the trabecular meshwork as well as other regions. Here, it is irrelevant whether what the laser treatment to be applied is.Type: ApplicationFiled: April 4, 2019Publication date: May 27, 2021Applicant: Carl Zeiss Meditec AGInventors: Manfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER
-
Patent number: 10973687Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.Type: GrantFiled: April 7, 2017Date of Patent: April 13, 2021Assignee: Carl Zeiss Meditec AGInventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer
-
Publication number: 20200268555Abstract: A device for superimposing parameters and/or image data in the stereoscopic observation path of ophthalmological devices relates to an apparatus for reflecting relevant parameters and/or image data into the stereoscopic observation beam path of ophthalmic devices, for example for therapeutic laser treatments of an eye. The device includes an additional micro-display, which is connected to the control unit, and a beam deflection element for reflecting the parameters and/or image data shown on the micro-display into the stereoscopic observation beam path, which are for example arranged in the parallel beam path. Even though the apparatus is intended for ophthalmic devices for therapeutic laser treatment in the eye, it can also be used, in principle, for ophthalmic devices for examination, diagnosis and surgical interventions.Type: ApplicationFiled: September 28, 2018Publication date: August 27, 2020Applicant: Carl Zeiss Meditec AGInventors: Manfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER, Rolf TEUSCHER
-
Publication number: 20190117461Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.Type: ApplicationFiled: April 7, 2017Publication date: April 25, 2019Applicant: Carl Zeiss Meditec AGInventors: Manfred DICK, Gerald Kunath-Fandrei, René DENNER, Thomas WURLITZER
-
Patent number: 9180052Abstract: A method for non-invasive temperature determination in biological tissue treated with treatment radiation wherein a reaction which depends on the treatment temperature is generated and detected. Measurement radiation pulses and pulses of the treatment radiation are applied to the tissue to be treated successively, in particular in an alternating way, from the same radiation source. A device includes a radiation source, an irradiation lens system, detectors for determining a reaction and a system control suitable for controlling treatment radiation and measurement radiation pulses. The system control generates successive, in particular alternating, pulses of treatment radiation and measurement radiation pulses from one radiation source only, in particular a laser which can be modulated.Type: GrantFiled: March 31, 2010Date of Patent: November 10, 2015Assignee: Carl Zeiss Meditec AGInventors: Manfred Dick, René Denner, Stefan Knoke
-
Publication number: 20130085481Abstract: A device intended to permit photocoagulation or phototherapy at low cost and in a shorter time. For this purpose, an ophthalmology appliance includes a radiation source having several discrete individual emitters. The therapy beam path leading from the radiation source to the treatment area projects an image of at least respective portions of different individual emitters simultaneously onto surfaces spaced apart from each other in the treatment area. This permits simultaneous generation of several coagulation foci and dispenses with the need for electromechanical beam-deflecting units, which permits a shorter treatment time.Type: ApplicationFiled: May 28, 2011Publication date: April 4, 2013Applicant: CARL ZEISS MEDITEC AGInventors: Manfred Dick, René Denner, Gerald Kunath-Fandrei
-
Publication number: 20120089132Abstract: A method for non-invasive temperature determination in biological tissue treated with treatment radiation wherein a reaction which depends on the treatment temperature is generated and detected. Measurement radiation pulses and pulses of the treatment radiation are applied to the tissue to be treated successively, in particular in an alternating way, from the same radiation source. A device includes a radiation source, an irradiation lens system, detectors for determining a reaction and a system control suitable for controlling treatment radiation and measurement radiation pulses. The system control generates successive, in particular alternating, pulses of treatment radiation and measurement radiation pulses from one radiation source only, in particular a laser which can be modulated.Type: ApplicationFiled: March 31, 2010Publication date: April 12, 2012Applicant: CARL ZEISS MEDITEC AGInventors: Manfred Dick, René Denner, Stefan Knoke